Company intelligence / Profile preview

Ultradent Products

South Jordan, Utah, United Statesultradent.com ↗

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Ultradent Products has a long-standing track record of commercial success in the global dental industry. Its flagship products—such as Astringedent™ hemostatic agent and Opalescence™ tooth whitening systems—are widely used by clinicians worldwide. The company holds numerous patents and continues to innovate across a broad portfolio of over 1,600 products distributed in more than 100 countries[2][4][5].

Therapeutic areas: Other
Modalities: DeviceBiologicSmall molecule
Industry: Therapeutic Medical Devices

Partnerships

No major pharma/biotech partnerships publicly disclosed; focus on direct sales and distribution.

Beyond the preview

Go deeper on Ultradent Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultradent Products.

Explore the full profile